Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000247694 | SCV000313735 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV001509736 | SCV001716592 | benign | Seizures, benign familial infantile, 3; Developmental and epileptic encephalopathy, 11 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001640569 | SCV001858219 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807194 | SCV002054530 | benign | Developmental and epileptic encephalopathy, 11 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807195 | SCV002054531 | benign | Episodic ataxia, type 9 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807193 | SCV002054532 | benign | Seizures, benign familial infantile, 3 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV000247694 | SCV005087441 | benign | not specified | 2024-07-15 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 71% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 66. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV001640569 | SCV005239611 | benign | not provided | criteria provided, single submitter | not provided | ||
Diagnostic Laboratory, |
RCV000247694 | SCV001743258 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000247694 | SCV001932445 | benign | not specified | no assertion criteria provided | clinical testing |